Print This Post
Carbon Dioxide as a Therapeutic in the P301S Mouse Model of Tauopathy - Dr Llywelyn Lee
This playlist contains recordings made at the Alzheimer’s Research UK Northern Networks Meeting held on the on 8th July 2024 at Newcastle University. The event brought together early career researchers from across the north of England to present their research.
Dementia Researcher recorded the event through our Open Access Events initative if you’re an event organisers, get in touch to see how we could support your event.
Speakers
Dr Llywelyn Lee is a Post Doctoral Research Associate at The University of Sheffield. He joined the Sheffield Neurovascular Lab in 2015 as a research technician, and is now a post-doc studying neurovascular coupling in Alzheimer’s Disease. He uses a range of techniques including 2-photon imaging, electrophysiology and behavioural tests to observe deficits in cerebral blood flow in Alzheimer’s disease. When not in the lab, he enjoy playing rugby and fishing.
Dr Hina Khan is a Consultant Neurologist within the NHS and at The University of Sheffield.
Caitlin Illingworth is a PhD Student at University of Sheffield. She graduated from the University of Bath in 2023 with a BSc in Psychology. As part of her degree, she undertook a year-long work placement at Brown University’s language and thought lab investigating developmental psycholinguistics with children aged 18 months to 8 years old. This evoked a passion for language which, combined with her focus on cognitive neuroscience, led her to join the CognoSpeak project working with Dr Daniel Blackburn at the University of Sheffield. She has worked as a Research Assistant, and is now undertaking a PhD with Dr Blackburn as her primary supervisor, investigating brain activity during verbal fluency tasks in monolinguals and bilinguals with the aim of developing a more appropriate memory assessment tool for patients across different language backgrounds.
Dr Osman Shabir is a BHF Research Fellow at University of Sheffield he studies neuroinflammation, neurovascular function (neurophysiology) in neurodegenerative and cerebrovascular diseases such as Alzheimer’s disease/vascular dementia & cardiovascular disease (atherosclerosis). He uses preclinical models of human disease to study neurophysiology, neuropathology & neuroinflammation in these models to gain a better understanding of disease mechanisms and processes.
Dr Elliot Atkinson is a Neuromuscular physiologist; Reticulospinal tract function, and Post – doctoral researcher in female veteran Brian health – FemBER working at Northumbria University.
Dr Daniel Erskine is an Alzheimer’s Research UK Fellow at Newcastle University. His research interest is in understanding cellular vulnerability in Lewy body disease: why Lewy bodies only seem to occur in some neurons but not others, and why only some neurons degenerate (and not only the ones with Lewy bodies!). His primary methods involve post-mortem analysis of human brain tissue, but I he is increasingly moving towards developing novel model systems, with an overriding focus on using human cell and tissue models as the best platform for understanding a uniquely human disease.
Dr Bridget Ashford is a Post doctoral research associate studying microvascular disease in dementia at The University of Shefield. Working in the in the Wharton / Simpson pathology research lab, SITraN.
Dr Bridget Bensen is a Post-doctoral researcher at the Sheffield Institute for Translational Neuroscience studying senescence in Alzheimer’s Disease. Interested in dementia, motor neuron disease, aging and neurodegeneration.
Suzan Elsheikh is a Research Assistant and Neuroscientist at Teesside University orking with biomedical science lecturer Dr Ahmad Khundakar.
Aimee Pick is a PhD Student Newcastle University. Her work is on SPLENDID which aims to understand how we ensure social prescribing is useful and helpful to people with dementia.
The Alzheimer’s Research UK Research Network is a unique, collaborative venture in the dementia research community.
First established in 1998, the Research Network now comprises of 12 Centres with a total of over 3,000 dementia researchers – both basic scientists and clinicians – around the UK.
About the Research Network
The Network is designed to support biomedical dementia research through the funding of collaborative science and networking to share findings and resources. The Network also serves to not only bring researchers into the dementia field but to disseminate research findings to the local community through annual Public Meetings.
How to get involved
The Alzheimer’s Research UK Research Network is open to all biomedical dementia researchers – from PhD students to tenured academics, basic scientists to clinicians. There are 12 Network Centres; some Centres are single institutions, others include researchers from geographically close academic institutions.
